Paper39090352
Efficiency of Cysticidal Therapy Impacted by the Host's Immune Response in Neurocysticercosis Patients.
Mehta Y and 7 others. Mol Neurobiol, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Efficiency of Cysticidal Therapy Impacted by the Host's Immune Response in Neurocysticercosis Patients. Papers, record 39090352. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39090352
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Efficiency of Cysticidal Therapy Impacted by the Host's Immune Response in Neurocysticercosis Patients.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neurocysticercosis | Major topic |
| Anthelmintics | Major topic |
| Immunity | Major topic |
| Humans | |
| Female | |
| Male | |
| Adult | |
| Cytokines | |
| Treatment Outcome | |
| Animals | |
| Young Adult | |
| Middle Aged | |
| Leukocytes, Mononuclear | |
| Adolescent | |
| Taenia solium |
Source PubMed
References19
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26506532 | A Comparative Study of Peripheral Immune Responses to Taenia solium in Individuals with Parenchymal and Subarachnoid Neurocysticercosis. | PLoS Negl Trop Dis | 2015 | https://conductscience.org/library/papers/26506532 | PubMed |
| 2 | 10774460 | Neurocysticercosis: updates on epidemiology, pathogenesis, diagnosis, and management. | Annu Rev Med | 2000 | https://conductscience.org/library/papers/10774460 | PubMed |
| 3 | 11401999 | Brain granulomas in neurocysticercosis patients are associated with a Th1 and Th2 profile. | Infect Immun | 2001 | https://conductscience.org/library/papers/11401999 | PubMed |
| 4 | 24717595 | Immune-inflammatory markers in massively disseminated cysticercosis. | BMJ Case Rep | 2014 | https://conductscience.org/library/papers/24717595 | PubMed |
| 5 | 24957954 | Neurocysticercosis: the effectiveness of the cysticidal treatment could be influenced by the host immunity. | Med Microbiol Immunol | 2014 | https://conductscience.org/library/papers/24957954 | PubMed |
| 6 | 15184592 | Calcific neurocysticercosis and epileptogenesis. | Neurology | 2004 | https://conductscience.org/library/papers/15184592 | PubMed |
| 7 | 34041288 | Neurocysticercosis: Current Perspectives on Diagnosis and Management. | Front Vet Sci | 2021 | https://conductscience.org/library/papers/34041288 | PubMed |
| 8 | 21171883 | Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease. | Expert Rev Anti Infect Ther | 2011 | https://conductscience.org/library/papers/21171883 | PubMed |
| 9 | 21698478 | Neurocysticercosis: local and systemic immune-inflammatory features related to severity. | Med Microbiol Immunol | 2012 | https://conductscience.org/library/papers/21698478 | PubMed |
| 10 | 32298263 | Host immune responses during Taenia solium Neurocysticercosis infection and treatment. | PLoS Negl Trop Dis | 2020 | https://conductscience.org/library/papers/32298263 | PubMed |
| 11 | 33269789 | The Local Inflammatory Profile and Predictors of Treatment Success in Subarachnoid Neurocysticercosis. | Clin Infect Dis | 2021 | https://conductscience.org/library/papers/33269789 | PubMed |
| 12 | 32985289 | Taenia solium proteins: a beautiful kaleidoscope of pro and anti-inflammatory antigens. | Expert Rev Proteomics | 2020 | https://conductscience.org/library/papers/32985289 | PubMed |
| 13 | 15258785 | Symptomatic human neurocysticercosis--age, sex and exposure factors relating with disease heterogeneity. | J Neurol | 2004 | https://conductscience.org/library/papers/15258785 | PubMed |
| 14 | 15935735 | Relationship between the clinical heterogeneity of neurocysticercosis and the immune-inflammatory profiles. | Clin Immunol | 2005 | https://conductscience.org/library/papers/15935735 | PubMed |
| 15 | 16138104 | Immunological processes in malaria pathogenesis. | Nat Rev Immunol | 2005 | https://conductscience.org/library/papers/16138104 | PubMed |
| 16 | 36054944 | The prevalence of and contributors to neurocysticercosis in endemic regions. | J Neurol Sci | 2022 | https://conductscience.org/library/papers/36054944 | PubMed |
| 17 | 22361029 | [Anti-inflammatory and immunosuppressive properties of corticosteroids]. | Presse Med | 2012 | https://conductscience.org/library/papers/22361029 | PubMed |
| 18 | 17689290 | Interleukin-10 and the pathogenesis of human visceral leishmaniasis. | Trends Immunol | 2007 | https://conductscience.org/library/papers/17689290 | PubMed |
| 19 | 36601353 | Neurocysticercosis: A Review into Treatment Options, Indications, and Their Efficacy. | Res Rep Trop Med | 2022 | https://conductscience.org/library/papers/36601353 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 40143182 | In Vitro Evaluation of Esters of Quinoxaline-1,4-di-N-oxide Derivatives as New Antitaeniasis Agents and Their Inhibitory Activity Against Triosephosphate Isomerase. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40143182 |
Source PubMed
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| IL10 | 3586 | PubTator's text mining | https://conductscience.org/library/genes/3586 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39090352
GET https://conductscience.org/api/papers/v1/39090352/authors